TY - JOUR A1 - Bein, Julia A1 - Flinner, Nadine A1 - Häupl, Björn A1 - Mathur, Aastha A1 - Schneider, Olga A1 - Abu-Ayyad, Marwa A1 - Hansmann, Martin-Leo A1 - Piel, Matthieu A1 - Oellerich, Thomas A1 - Hartmann, Sylvia T1 - T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma T2 - Journal of cellular and molecular medicine N2 - Classic Hodgkin lymphoma (cHL) is usually characterized by a low tumour cell content, derived from crippled germinal centre B cells. Rare cases have been described in which the tumour cells show clonal T-cell receptor rearrangements. From a clinicopathological perspective, it is unclear if these cases should be classified as cHL or anaplastic large T-cell lymphoma (ALCL). Since we recently observed differences in the motility of ALCL and cHL tumour cells, here, we aimed to obtain a better understanding of T-cell-derived cHL by investigating their global proteomic profiles and their motility. In a proteomics analysis, when only motility-associated proteins were regarded, T-cell-derived cHL cell lines showed the highest similarity to ALK− ALCL cell lines. In contrast, T-cell-derived cHL cell lines presented a very low overall motility, similar to that observed in conventional cHL. Whereas all ALCL cell lines, as well as T-cell-derived cHL, predominantly presented an amoeboid migration pattern with uropod at the rear, conventional cHL never presented with uropods. The migration of ALCL cell lines was strongly impaired upon application of different inhibitors. This effect was less pronounced in cHL cell lines and almost invisible in T-cell-derived cHL. In summary, our cell line-derived data suggest that based on proteomics and migration behaviour, T-cell-derived cHL is a neoplasm that shares features with both cHL and ALCL and is not an ALCL with low tumour cell content. Complementary clinical studies on this lymphoma are warranted. KW - anaplastic large cell lymphoma KW - Hodgkin lymphoma KW - motility Y1 - 2022 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/79351 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-793515 SN - 1582-4934 N1 - This project was supported by the Deutsche Forschungsgemeinschaft (grant HA6145/6-1). N1 - Open Access funding enabled and organized by Projekt DEAL. N1 - The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE22 partner repository with the dataset identifier PXD031907 (https://www.ebi.ac.uk/pride). Raw data of movies are available on request from the corresponding author (several hundred Megabytes for each movie). VL - 26 IS - 12 SP - 3495 EP - 3505 PB - Wiley-Blackwell CY - Hoboken, NJ ER -